Stem Cell Therapy Market Research Report – Global Forecast to 2027

Stem Cell Therapy Market Research Report, by Type (Allogeneic, Autologous), by Product Type (Antibodies, Kits), by Application (Clinical Research), & by End-User (Clinical Diagnostics, Hospitals & Research Institutes) – Global Forecast Till 2027

ID: MRFR/LS/4961-HCR | | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global stem cell therapy market is expected to reach an approximate CAGR of 10.3% during the forecast period. The use of stem cell for treating medical conditions is referred to as stem cell therapy. Stem cells are undifferentiated cells and differentiate into specialized cell types. This ability of stem cells to differentiate into cells of interest is used to treat diseases like diabetes, heart disease, hematopoietic disorders (for example leukemia, thalassemia, and others), degenerative disorders (osteoarthritis, Alzheimer’s disease, Parkinson’s disease, chronic renal failure, congestive cardiac failure,) and others.


Key factors responsible for the market growth are the rising awareness for therapeutic application of stem cells in disease management, rising research for stem cell therapy applications, development of advanced genetic analysis techniques, increasing public-private investments for stem cell research, growing research in identification of new stem cell lines, and new developments in stem cell banking infrastructure are driving the growth of the global stem cell therapy market. Stem cells are used in the treatment of Alzheimer’s by replacing the diseased cells with stem cells. This approach has great potential in preventing or halting several neurodegenerative diseases like Alzheimer’s.  According to the Alzheimer's Association in 2018, 5.7 million Americans are affected by Alzheimer’s disease.  Thus, such a high incidence of neurological diseases and increasing government funding enhances the growth in this market.


However, factors such as, difficulty in collection and storage procedures of somatic stem cells, chances of cross contaminations, shortage of skilled labor expensive procedures and regulatory complications are expected to restrict the market growth during the forecast period.


Segmentation


The global stem cell therapy market is segmented on the basis of type, therapeutic application, cell source, and end-user. The stem cell therapy market, by type, is sub-segmented into Allogeneic and Autologous.


On the basis of therapeutic application, the market is categorized into medicine, cardiovascular diseases, bone regeneration, neurodegenerative disorders, wound healing, treatment of eyes, hematopoietic disorders, metabolic disorders, cancer, immunodeficiency, and diabetes. Cell source is further sub-segmented into adipose tissue, bone marrow, neural, embryo/cord blood-derived, iPSCs. On the basis of end-user, the market is segmented into biotechnology companies, hospitals & research institutes, contract research organizations and stem cell banks.


On the basis of region, the global stem cell therapy market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.


The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key players


Some of the key players are Osiris Therapeutics, Inc. (US), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (US), RTI Surgical, Inc. (US), and AlloSource (US), Thermo Fisher Scientific are some of the key players operating in the global stem cell therapy market. 


Regional Market Summary


Global Stem Cell Therapy Market Share (%), by Region, 2017


Stem Cell Therapy Market Share


Sources: National Institutes of Health, US Investments in Medical and Health Research and Development, Department of Biotechnology, Department of Science and Technology


The stem cell therapy market is dominated by North America owing to the high prevalence of chronic diseases and high R&D investments within this region stimulate market growth. According to the US Investments in Medical and Health Research and Development in 2016, the United States invested total USD171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of diseases drives the market growth in this region.


It is estimated that Europe stood second in the global stem cell therapy market. Rising prevalence of chronic diseases such as cancer is driving the growth of this market in Europe. According to the Eurostat in 2014, 272 thousand people deaths were due to lung cancer. Thus, increasing prevalence of cancer in Europe drives the market growth. Furthermore, the rapidly growing biotechnology sector in Europe is expected to boost the market in this region.


Asia-Pacific was projected to be the fastest growing region for the global stem cell therapy market. Key factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in the biotechnology sector influences the market in this region. Also, the presence of major market players in China, India, and Japan drives the market growth.


The Middle East and Africa holds the least share in the global stem cell therapy market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth. 


Market Segmentation


Global Stem Cell Therapy Market, by Technique,



  • Primary (Direct) Stem Cell Therapy

  • Secondary (Indirect) Stem Cell Therapy

    • Salt split technique

    • Antigenic mapping method

    • Double staining method



  • Micro Immunofluorescence


Global Stem Cell Therapy Market, by Product Type



  • Antibodies

  • Kits and reagents

  • Instruments

  • Microscopes

  • Imaging Analysis Systems

  • Labeling dyes

  • Species Product Type


Global Stem Cell Therapy Market, by Application



  • Clinical research

  • Clinical Diagnostics

  • Infectious Diseases

  • Cancer

  • Cardiovascular Diseases

  • Autoimmune Diseases

  • Neurological Diseases

  • Research & Development


Global Stem Cell Therapy Market, by End-User



  • Biotechnology Companies

  • Hospitals & Research Institutes

  • Contract Research Organizations

  • Diagnostic centers


Global Stem Cell Therapy Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Global Stem Cell Therapy Market, by Key Players



  • Abcam plc

  • Thermo Fisher Scientific

  • BioLegend, Inc.

  • Enzo Life Sciences, Inc.

  • Sino Biological Inc.

  • BioTek Instruments, Inc.

  • Bio-Rad Laboratories, Inc.

  • Zyagen

  • Cell Signaling Technology, Inc.

  • PerkinElmer Inc.

  • Becton Dickinson and Company

  • Merck

  • Agilent Technologies

  • TCS Biosciences Ltd

  • Maxvision Biosciences Inc.

  • Others


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers



Frequently Asked Questions (FAQ) :


The major factors are a better investment in research, increasing awareness related to therapeutic applications, the inclusion of advanced genetic analysis technologies, various disease management procedures, and others.

Difficulties regarding collection and storage can hamper market growth.

Stem cell therapy market would get backed by the Americas the most.

The players are MEDIPOST Co., Ltd. (South Korea), Osiris Therapeutics, Inc. (US), Holostem Terapie Avanzate S.r.l. (Italy), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), NuVasive, Inc. (US), RTI Surgical, Inc. (US), JCR Pharmaceuticals Co., Ltd. (Japan), and AlloSource (US), Thermo Fisher Scientific, and others.

The segments are bone regeneration, medicine, cardiovascular diseases, treatment of eyes, neurodegenerative disorders, wound healing, metabolic disorders, hematopoietic disorders, immunodeficiency, cancer, and diabetes.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Stem Cell Therapy Market, by Type

6.1 Introduction

6.2 Allogeneic

6.3 Autologous

Chapter 7. Global Stem Cell Therapy Market, by Therapeutic Application

7.1 Introduction

7.2 Medicine

7.3 Cardiovascular Diseases

7.4 Bone Regeneration

7.5 Neurodegenerative Disorders

7.6 Wound Healing

7.7 Treatment of Eyes

7.8 Hematopoietic Disorders

7.9 Metabolic Disorders

7.10 Cancer

7.11 Immunodeficiency

7.12 Diabetes

Chapter 8. Global Stem Cell Therapy Market, by Cell source

8.1 Introduction

8.2 Adipose tissue

8.3 Bone Marrow

8.3 Neural

8.4 Embryo/Cord Blood-Derived

8.5 iPSCs

Chapter 9. Global Stem Cell Therapy Market, by End -User

9.1 Introduction

9.2 Biotechnology Companies

9.3 Hospitals & Research Institutes

9.4 Contract Research Organizations

9.5 Stem cell banks

Chapter 10. Global Stem Cell Therapy Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Osiris Therapeutics, Inc.

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 MEDIPOST Co., Ltd.

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Anterogen Co., Ltd.

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Pharmicell Co., Ltd.

12.4.1 Company Overview

12.4.2 Product Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Holostem Terapie Avanzate S.r.l.

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 JCR Pharmaceuticals Co., Ltd.

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 NUVASIVE, INC

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 RTI Surgical, Inc.

12.8.1 Overview

12.8.2 Product Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 AlloSource

12.9.1 Overview

12.9.2 Product Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Thermo Fisher Scientific

12.10.1 Overview

12.10.2 Product Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 14 Appendix

LIST OF TABLES

Table 1 Stem Cell Therapy Market Industry Synopsis, 2020-2027

Table 2 Global Stem Cell Therapy Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Stem Cell Therapy Market, by Region, 2020-2027, (USD Million)

Table 4 Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 5 Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 7 Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 8 Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million

Table 9 North America: Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 10 North America: Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 12 North America: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 13 North America: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million)

Table 14 US: Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 15 US: Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 17 US: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 18 US: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million)

Table 19 Canada: Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 20 Canada: Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 22 Canada: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 23 Canada: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million)

Table 24 South America: Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 25 South America: Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 27 South America: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 28 South America: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million)

Table 29 Europe: Global Stem Cell Therapy Market, Type, 2020-2027, (USD Million)

Table 30 Europe: Global Stem Cell Therapy Market, Therapeutic Application, 2020-2027, (USD Million)

Table 32 Europe: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 33 Europe: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million)

Table 34 Western Europe: Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 35 Western Europe: Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 37 Western Europe: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 38 Western Europe: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million

Table 39 Eastern Europe: Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 40 Eastern Europe: Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 42 Eastern Europe: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 43 Eastern Europe: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million)

Table 44 Asia-Pacific: Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 45 Asia-Pacific: Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 47 Asia-Pacific: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 48 Asia-Pacific: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million)

Table 49 Middle East & Africa: Global Stem Cell Therapy Market, by Type, 2020-2027, (USD Million)

Table 50 Middle East & Africa: Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2027, (USD Million)

Table 52 Middle East & Africa: Global Stem Cell Therapy Market, by Cell Source, 2020-2027, (USD Million)

Table 53 Middle East & Africa: Global Stem Cell Therapy Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for the Global Stem Cell Therapy Market

Figure 3 Market Dynamics for Global Stem Cell Therapy Market

Figure 4 Global Stem Cell Therapy Market Share, by Type 2020

Figure 4 Global Stem Cell Therapy Market Share, by Product Type 2020

Figure 5 Global Stem Cell Therapy Market Share, by Cell Source 2020

Figure 6 Global Stem Cell Therapy Market Share, by End-User, 2020

Figure 7 Global Stem Cell Therapy Market Share, by Region, 2020

Figure 8 North America Stem Cell Therapy Market Share, by Country, 2020

Figure 9 Europe Stem Cell Therapy Market Share, by Country, 2020

Figure 10 Asia-Pacific Stem Cell Therapy Market Share, by Country, 2020

Figure 11 Middle East & Africa Stem Cell Therapy Market Share, by Country, 2020

Figure 12 Global Stem Cell Therapy Market: Company Share Analysis, 2020 (%)

Figure 13 Osiris Therapeutics, Inc.: Key Financials

Figure 14 Osiris Therapeutics, Inc.: Segmental Revenue

Figure 15 Osiris Therapeutics, Inc.: Geographical Revenue

Figure 16 MEDIPOST Co., Ltd.: Key Financials

Figure 17 MEDIPOST Co., Ltd.: Segmental Revenue

Figure 18 MEDIPOST Co., Ltd.: Geographical Revenue

Figure 19 Anterogen Co., Ltd.: Key Financials

Figure 20 Anterogen Co., Ltd.: Segmental Revenue

Figure 21 Anterogen Co., Ltd.: Geographical Revenue

Figure 22 Pharmicell Co., Ltd.: Key Financials

Figure 23 Pharmicell Co., Ltd.: Segmental Revenue

Figure 24 Pharmicell Co., Ltd.: Geographical Revenue

Figure 25 JCR Pharmaceuticals Co., Ltd.: Key Financials

Figure 26 JCR Pharmaceuticals Co., Ltd.: Segmental Revenue

Figure 27 JCR Pharmaceuticals Co., Ltd.: Geographical Revenue

Figure 28 Holostem Terapie Avanzate S.r.l.: Key Financials

Figure 29 Holostem Terapie Avanzate S.r.l. : Segmental Revenue

Figure 30 Holostem Terapie Avanzate S.r.l.: Geographical Revenue

Figure 31 NUVASIVE, INC: Key Financials

Figure 32 NUVASIVE, INC: Segmental Revenue

Figure 33 NUVASIVE, INC: Geographical Revenue

Figure 34 RTI Surgical, Inc.: Key Financials

Figure 35 RTI Surgical, Inc.: Segmental Revenue

Figure 36 RTI Surgical, Inc.: Geographical Revenue

Figure 37 AlloSource: Key Financials

Figure 38 AlloSource: Segmental Revenue

Figure 39 AlloSource: Geographical Revenue

Figure 40 Thermo Fisher Scientific: Key Financials

Figure 41 Thermo Fisher Scientific: Segmental Revenue

Figure 42 Thermo Fisher Scientific: Geographical Revenue